Arcturus Therapeutics Holdings Depreciation & Amortization 2011-2025 | ARCT

Annual Depreciation & Amortization Arcturus Therapeutics Holdings

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
3.54 M	2.96 M	1.53 M	1.19 M	882 K	684 K	582 K	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
3.54 M	582 K	1.62 M

Quarterly Depreciation & Amortization Arcturus Therapeutics Holdings

2025-Q3	2025-Q2	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
800 K	800 K	-	900 K	900 K	904 K	-	800 K	700 K	578 K	-	400 K	400 K	224 K	-	300 K	300 K	307 K	-	200 K	200 K	182 K	-	200 K	200 K	172 K	-	200 K	100 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
904 K	100 K	444 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
ADiTx Therapeutics ADTX	614 K	$ 2.49	-11.39 %	$ 32.8 K	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Abeona Therapeutics ABEO	2.29 M	$ 4.59	-4.08 %	$ 98.1 M	USA
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Amneal Pharmaceuticals AMRX	62.6 M	$ 12.12	-1.58 %	$ 3.74 B	USA
Axcella Health AXLA	412 K	-	-16.42 %	$ 249 M	USA
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
Armata Pharmaceuticals ARMP	972 K	$ 5.37	-20.68 %	$ 194 M	USA
Atreca BCEL	5.46 M	-	-11.76 %	$ 5.79 M	USA
Brainstorm Cell Therapeutics BCLI	240 K	-	-2.5 %	$ 5.88 M	USA
Achieve Life Sciences ACHV	228 K	$ 4.64	-0.32 %	$ 92 M	USA
BioDelivery Sciences International BDSI	140 K	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	172 M	-	0.49 %	$ 251 B	Cayman-islands
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
BioMarin Pharmaceutical BMRN	96.4 M	$ 54.27	-1.38 %	$ 10.3 B	USA
Adaptimmune Therapeutics plc ADAP	9.45 M	-	-15.15 %	$ 60.3 M	Britain
Baudax Bio BXRX	165 K	-	0.59 %	$ 63 K	USA
AbbVie ABBV	764 M	$ 224.99	-0.01 %	$ 398 B	USA
Cara Therapeutics CARA	259 K	-	-3.03 %	$ 260 M	USA
CymaBay Therapeutics CBAY	681 K	-	-	$ 3.45 B	USA
ChemoCentryx CCXI	3.14 M	-	-	$ 3.74 B	USA
Codiak BioSciences CDAK	5.34 M	-	-55.98 %	$ 2.15 M	USA
Adaptive Biotechnologies Corporation ADPT	19.3 M	$ 18.75	-0.48 %	$ 2.76 B	USA
Avid Bioservices CDMO	11.1 M	-	-	$ 789 M	USA
BioXcel Therapeutics BTAI	309 K	$ 1.92	-7.01 %	$ 4.87 M	USA
Biogen BIIB	673 M	$ 179.76	1.11 %	$ 26.2 B	USA
Cerevel Therapeutics Holdings CERE	5.63 M	-	-	$ 7.29 B	USA
ContraFect Corporation CFRX	154 K	-	-5.16 %	$ 5.39 M	USA
Beam Therapeutics BEAM	21.9 M	$ 23.52	-2.22 %	$ 1.94 B	USA
AbCellera Biologics ABCL	12.5 M	$ 3.45	-0.72 %	$ 1.02 B	Canada
Cabaletta Bio CABA	1.43 M	$ 2.37	-2.67 %	$ 2.77 M	USA
Clearside Biomedical CLSD	67 K	-	-	$ 25.3 M	USA
Celsion Corporation CLSN	240 K	-	-6.63 %	$ 13.9 M	USA
Clovis Oncology CLVS	8.5 M	-	-7.23 %	$ 13 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Checkmate Pharmaceuticals CMPI	66 K	-	-	$ 231 M	USA
Chimerix CMRX	91 K	-	-	$ 756 M	USA
Concert Pharmaceuticals CNCE	1.48 M	-	-	$ 401 M	USA